1 Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
2 Molecular Cancer Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
3 Department of Urology, University of Pittsburgh/UPMC, Pittsburgh, Pennsylvania.
4 Department of Ophthalmology, University of Pittsburgh/UPMC, Pittsburgh, Pennsylvania.
5 Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
6 Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark.
7 Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
8 Section of Ophthalmology, Department of Head & Neck Surgery, Division of Surgery, MD Anderson Cancer Center, Houston, Texas.
9 Department of Internal Medicine, MEND, Division of Genetic Medicine, University of Michigan, Ann Arbor, Michigan.
10 Department of Ophthalmology, University of Michigan, Ann Arbor, Michigan.
11 Division of Medical Oncology at Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
12 Department of Ophthalmology, University of Utah, Salt Lake City, Utah; Department of Ophthalmology, Byers Eye Institute at Stanford University, Palo Alto, California.
13 VOIANT (Independent Reading Center), Boston, Massachusetts; Department of Ophthalmology, Columbia University, New York, NY.
14 Merck & Co., Inc., Rahway, New Jersey.
15 Urologic Oncology Branch, National Cancer Institute, Bethesda, Maryland.
16 Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: echew@nei.nih.gov.